216 related articles for article (PubMed ID: 25596046)
21. Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes.
Hadziahmetovic M; Loo BW; Timmerman RD; Mayr NA; Wang JZ; Huang Z; Grecula JC; Lo SS
Discov Med; 2010 May; 9(48):411-7. PubMed ID: 20515609
[TBL] [Abstract][Full Text] [Related]
22. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
[TBL] [Abstract][Full Text] [Related]
23. Stereotactic body radiation therapy in multiple organ sites.
Timmerman RD; Kavanagh BD; Cho LC; Papiez L; Xing L
J Clin Oncol; 2007 Mar; 25(8):947-52. PubMed ID: 17350943
[TBL] [Abstract][Full Text] [Related]
24. Stereotactic body radiotherapy: volumetric modulated arc therapy versus 3D non-coplanar conformal radiotherapy for the treatment of early stage lung cancer.
Herbert C; Kwa W; Nakano S; James K; Moiseenko V; Wu J; Schellenberg D; Liu M
Technol Cancer Res Treat; 2013 Dec; 12(6):511-6. PubMed ID: 23617285
[TBL] [Abstract][Full Text] [Related]
25. Stereotactic body radiation therapy: A novel treatment modality for inoperable hepatocellular carcinoma.
Meng M; Wang H; Zeng X; Zhao L; Yuan Z; Wang P; Hao X
Drug Discov Ther; 2015 Oct; 9(5):372-9. PubMed ID: 26632546
[TBL] [Abstract][Full Text] [Related]
26. Metabolic liver function after stereotactic body radiation therapy for hepatocellular carcinoma.
Dreher C; Høyer KI; Fode MM; Habermehl D; Combs SE; Høyer M
Acta Oncol; 2016 Jul; 55(7):886-91. PubMed ID: 26878669
[TBL] [Abstract][Full Text] [Related]
27. Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases.
Kavanagh BD; McGarry RC; Timmerman RD
Semin Radiat Oncol; 2006 Apr; 16(2):77-84. PubMed ID: 16564443
[TBL] [Abstract][Full Text] [Related]
28. A prospective study of the safety and efficacy of liver stereotactic body radiotherapy in patients with and without prior liver-directed therapy.
Moon DH; Wang AZ; Tepper JE
Radiother Oncol; 2018 Mar; 126(3):527-533. PubMed ID: 29366521
[TBL] [Abstract][Full Text] [Related]
29. Stereotactic body radiation therapy for hepatocellular carcinoma.
Lo SS; Dawson LA; Kim EY; Mayr NA; Wang JZ; Huang Z; Cardenes HR
Discov Med; 2010 May; 9(48):404-10. PubMed ID: 20515608
[TBL] [Abstract][Full Text] [Related]
30. Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033).
Crabtree T; Puri V; Timmerman R; Fernando H; Bradley J; Decker PA; Paulus R; Putnum JB; Dupuy DE; Meyers B
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):692-9. PubMed ID: 23174176
[TBL] [Abstract][Full Text] [Related]
31. Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials.
Powell JW; Dexter E; Scalzetti EM; Bogart JA
Lancet Oncol; 2009 Sep; 10(9):885-94. PubMed ID: 19717090
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.
Feddock J; Arnold SM; Shelton BJ; Sinha P; Conrad G; Chen L; Rinehart J; McGarry RC
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1325-31. PubMed ID: 23265574
[TBL] [Abstract][Full Text] [Related]
33. A propensity-matched analysis of wedge resection and stereotactic body radiotherapy for early stage lung cancer.
Port JL; Parashar B; Osakwe N; Nasar A; Lee PC; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2014 Oct; 98(4):1152-9. PubMed ID: 25085557
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma.
Price TR; Perkins SM; Sandrasegaran K; Henderson MA; Maluccio MA; Zook JE; Tector AJ; Vianna RM; Johnstone PA; Cardenes HR
Cancer; 2012 Jun; 118(12):3191-8. PubMed ID: 22025126
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy and hepatocellular carcinoma: update and review of the literature.
Ursino S; Greco C; Cartei F; Colosimo C; Stefanelli A; Cacopardo B; Berretta M; Fiorica F
Eur Rev Med Pharmacol Sci; 2012 Oct; 16(11):1599-604. PubMed ID: 23111978
[TBL] [Abstract][Full Text] [Related]
36. Imaging post-stereotactic body radiation therapy responses for hepatocellular carcinoma: typical imaging patterns and pitfalls.
Mastrocostas K; Jang HJ; Fischer S; Dawson LA; Munoz-Schuffenegger P; Sapisochin G; Kim TK
Abdom Radiol (NY); 2019 May; 44(5):1795-1807. PubMed ID: 30710166
[TBL] [Abstract][Full Text] [Related]
37. Hypofractionation in Hepatocellular Carcinoma - The Effect of Fractionation Size.
Lewis S; Barry A; Hawkins MA
Clin Oncol (R Coll Radiol); 2022 May; 34(5):e195-e209. PubMed ID: 35314091
[TBL] [Abstract][Full Text] [Related]
38. Repeat stereotactic body radiation therapy for patients with pulmonary malignancies who had previously received SBRT to the same or an adjacent tumor site.
Valakh V; Miyamoto C; Micaily B; Chan P; Neicu T; Li S
J Cancer Res Ther; 2013; 9(4):680-5. PubMed ID: 24518717
[TBL] [Abstract][Full Text] [Related]
39. Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.
Huang WY; Jen YM; Lee MS; Chang LP; Chen CM; Ko KH; Lin KT; Lin JC; Chao HL; Lin CS; Su YF; Fan CY; Chang YW
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):355-61. PubMed ID: 22342300
[TBL] [Abstract][Full Text] [Related]
40. Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients.
Sanuki N; Takeda A; Oku Y; Mizuno T; Aoki Y; Eriguchi T; Iwabuchi S; Kunieda E
Acta Oncol; 2014 Mar; 53(3):399-404. PubMed ID: 23962244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
